Fatal hepatotoxicity associated with 6-mercaptopurine therapy.
作者信息
Laidlaw S T, Reilly J T, Suvarna S K
出版信息
Postgrad Med J. 1995 Oct;71(840):639. doi: 10.1136/pgmj.71.840.639.
Abstract
摘要
相似文献
1
Fatal hepatotoxicity associated with 6-mercaptopurine therapy.与6-巯基嘌呤治疗相关的致命性肝毒性。
Postgrad Med J. 1995 Oct;71(840):639. doi: 10.1136/pgmj.71.840.639.
2
Proton pump inhibitor therapy in chemotherapy-induced pancreatitis.质子泵抑制剂疗法用于化疗引起的胰腺炎
J Pediatr Hematol Oncol. 2014 Nov;36(8):660-1. doi: 10.1097/MPH.0b013e318290bf31.
3
Recurrent mercaptopurine-induced acute pancreatitis: a rare complication of chemotherapy for acute lymphoblastic leukemia in children.复发性巯嘌呤诱发的急性胰腺炎：儿童急性淋巴细胞白血病化疗的一种罕见并发症。
Med Pediatr Oncol. 2002 Jan;38(1):73-4. doi: 10.1002/mpo.1273.
4
6-mercaptopurine: efficacy and bone marrow toxicity in childhood acute lymphoblastic leukemia. Association with low (thio)purine enzyme activity.6-巯基嘌呤：儿童急性淋巴细胞白血病的疗效与骨髓毒性。与低（硫）嘌呤酶活性的关联。
Adv Exp Med Biol. 2000;486:271-5. doi: 10.1007/0-306-46843-3_53.
5
Allopurinol Use During Maintenance Therapy for Acute Lymphoblastic Leukemia Avoids Mercaptopurine-related Hepatotoxicity.急性淋巴细胞白血病维持治疗期间使用别嘌醇可避免巯嘌呤相关的肝毒性。
J Pediatr Hematol Oncol. 2016 Mar;38(2):147-51. doi: 10.1097/MPH.0000000000000499.
6
The activity of the inosine triphosphate pyrophosphatase affects toxicity of 6-mercaptopurine during maintenance therapy for acute lymphoblastic leukemia in Japanese children.肌苷三磷酸焦磷酸酶的活性会影响日本儿童急性淋巴细胞白血病维持治疗期间 6-巯基嘌呤的毒性。
Leuk Res. 2012 May;36(5):560-4. doi: 10.1016/j.leukres.2011.11.015. Epub 2011 Dec 24.
7
Heritage-specific mechanisms for cancer adverse reactions: one gene does not explain the world.癌症不良反应的特定遗传机制：一个基因无法解释全部情况。
J Clin Oncol. 2015 Apr 10;33(11):1230-1. doi: 10.1200/JCO.2014.60.1740. Epub 2015 Mar 9.
8
Genetic polymorphisms of thiopurine S-methyltransferase and 6-mercaptopurine toxicity in Japanese children with acute lymphoblastic leukaemia.日本急性淋巴细胞白血病患儿硫嘌呤甲基转移酶的基因多态性与6-巯基嘌呤毒性
Pharmacogenetics. 2001 Apr;11(3):269-73. doi: 10.1097/00008571-200104000-00011.
9
Acquired factor V deficiency in the setting of mercaptopurine therapy for acute lymphoblastic leukemia.急性淋巴细胞白血病巯嘌呤治疗过程中获得性因子V缺乏症。
Ann Hematol. 2022 May;101(5):1137-1139. doi: 10.1007/s00277-021-04688-5. Epub 2021 Oct 6.
10
Use of allopurinol to reduce hepatotoxicity from 6-mercaptopurine (6-MP) in patients with acute lymphoblastic leukemia (ALL).在急性淋巴细胞白血病（ALL）患者中使用别嘌呤醇降低6-巯基嘌呤（6-MP）所致的肝毒性。
Leuk Lymphoma. 2020 May;61(5):1246-1249. doi: 10.1080/10428194.2019.1702183. Epub 2019 Dec 16.
引用本文的文献
1
Dose adaptation of antineoplastic drugs in patients with liver disease.肝病患者抗肿瘤药物的剂量调整
Drug Saf. 2006;29(6):509-22. doi: 10.2165/00002018-200629060-00004.
本文引用的文献
1
HEPATOTOXICITY OF MERCAPTOPURINE.巯嘌呤的肝毒性
JAMA. 1964 Jun 1;188:802-6. doi: 10.1001/jama.1964.03060350028007.
2
Mercaptopurine hepatotoxicity in a patient with chronic active hepatitis.一名慢性活动性肝炎患者的巯嘌呤肝毒性
Arch Intern Med. 1967 Dec;120(6):729-34.
3
Immunosuppressive and cytotoxic chemotherapy: long-term complications.
Ann Intern Med. 1975 Jan;82(1):84-95. doi: 10.7326/0003-4819-82-1-84.
Zotero 插件